知镜 Cognispect · 医学文献与研究工作台

ERN-RITA/PReS recommendations for the diagnosis, classification, monitoring, and treatment of childhood idiopathic (primary) angiitis of the central nervous system.

Constantin T, Takács K, Feldman B, Anastasa Z, Anton J, Berg S, Børresen ML, Caorsi R, Cattalini M, Csóka M, Dobner S, Dusser P, Federici S, Gattorno M, Gellért M, Gómez-Chiari M, Hansmann S, Hemingway C, Horváth Z, Jelušić M, Koné-Paut I, Lim M, Mankad K, Nardai S, Ogbu EA, Ozen S, Ravelli A, Simonini G, Szabó A, Szabados M, Smiechowicz J, Twilt M, Vecserka H, Vojinović J, Weiser P, Wickström R, Zajc Avramovič M, Brogan P, Benseler SM.
Annals of the rheumatic diseases · 2026-11-12 · PMID 43020703

文献摘要

Objectives Childhood central nervous system (CNS) vasculitis is a rare and serious disease for which no evidence-based consensus guidance, standardised terminology, or definitions of treatment response exist. We aimed to develop the first international recommendations for the diagnosis, classification, monitoring, and treatment of CNS vasculitis in children. Methods Adapting the European Alliance of Associations for Rheumatology standardised operating procedures, an international multidisciplinary panel of 42 experts from 15 countries was assembled through the European Reference Network on Rare Immunodeficiency, Autoinflammatory, Autoimmune and Paediatric Rheumatic Diseases, and the Paediatric Rheumatology European Society. A systematic literature review across 4 databases identified 182 eligible studies, graded per the Oxford Centre for Evidence-Based Medicine hierarchy. A modified Delphi survey (42 respondents) was followed by a 2-day face-to-face consensus conference (26 voting members; ≥70% agreement required). Results The panel formulated 83 consensus statements (3 overarching principles, 14 principles, and 66 recommendations) across 7 clinical domains. Of 182 included articles, 152 (83.5%) reported paediatric data; no level 1 evidence was identified. Key advances include an 8-domain nomenclature system replacing the 'primary/secondary' dichotomy with 'idiopathic/disease-associated' terminology, a paediatric-specific vessel wall imaging interpretive principle, a prospective risk-stratification model for disease progression, genome-wide sequencing as the preferred genetic testing approach, and formal definitions of remission, relapse, and refractory disease. None of these elements had been previously codified for childhood CNS vasculitis. Conclusions These recommendations establish a comprehensive, evidence-graded framework for childhood CNS vasculitis. The absence of level 1 evidence across all domains points to the need for an international prospective registry and collaborative clinical trials.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。